Your session is about to expire
← Back to Search
Bisphosphonates for Osteoporosis Prevention After Denosumab
Study Summary
This trial is being done to see if taking bisphosphonates after stopping denosumab will help prevent bone loss in premenopausal women with idiopathic osteoporosis.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have experienced problems with taking calcium supplements in the past.Women who have taken Forteo and denosumab for at least 12 months in previous research studies, without certain medical conditions or medications, can join this study.You have had a stomach or intestine condition in the past year.Your kidneys or liver are not working well, or you have abnormal levels of certain substances in your blood.You have certain health conditions or history that make it unsafe for you to take bisphosphonate medication.You have reported or are known to have abused alcohol or drugs in the past year.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What medical conditions does alendronate typically treat?
"Alendronate has been demonstrated to help ameliorate symptoms of tumors, solid masses, osteoporosis and malignant neoplasms."
Has alendronate received the endorsement of the FDA?
"Our Power analysts assigned alendronate a rating of 2 on their safety scale, as the drug has been through initial trials and there is some evidence that it can be used safely but no data to support its efficacy."
What is the scope of individuals involved in this clinical experiment?
"Affirmative. Per the information posted on clinicaltrials.gov, this experiment is in need of participants and had been modified as recently as January 25th 2021. The trial requires 34 individuals to be recruited from two separate sites."
Are there any eligibility criteria which would preclude me from participating in this research?
"This clinical trial seeks to recruit 34 individuals with osteoporosis, aged between 20 and 55. The essential requisites for enrollment are that participants have had 12 months of Forteo treatment and at least 1 year of denosumab as part of a past study. Additionally, they must not present any medical issue or history related medication exposure listed in the protocol."
Are there any other research endeavors that have utilized alendronate?
"Alendronate first made its clinical debut at Rosemere Cancer Centre, Royal Preston Hospital in 2005. Nowadays, there are 46 active trials and a total of 240 completed investigations. Notably, many of these studies are hosted out of Omaha, Nebraska."
Do you accept participants aged under 60 years for this trial?
"The age range for this trial is delineated by the eligibility criteria, which states that participants have to be between 20 and 55 years old."
Are any further participants being recruited into this clinical experiment?
"Affirmative. According to the data posted on clinicaltrials.gov, this medical study is actively enrolling patients; it was initially released on January 29th 2018 and recently updated in late 2021. The trial needs 34 participants from two different locations for full completion."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger